Initial data from a pair of clinical trials may revive interest in arthritis drugs as COVID-19 treatments
There is some renewed hope for rheumatoid arthritis drugs like Eli Lilly’s Olumiant and Roche’s Actemra as possible COVID-19 treatments […]
Learn more →






